Dr. Van Poznak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1500 East Medical Center Drive, Ann Arbor, Michigan
Ann Arbor, MI 48109Phone+1 734-936-9209Fax+1 734-215-2109- Is this information wrong?
Summary
- Dr. Catherine Van Poznak is an oncologist at the University of Michigan in Ann Arbor, MI. She received her medical degree from Weill Cornell Medical College of Cornell University and has been in practice 21 years. She specializes in breast cancer.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1998 - 2001
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1995 - 1998
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHInternship, Internal Medicine, 1995 - 1996
- Weill Cornell MedicineClass of 1995
Certifications & Licensure
- MI State Medical License 2006 - 2026
- NY State Medical License 1996 - 2023
- PA State Medical License 1995 - 1996
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 10 citationsTreatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline.Ghada El-Hajj Fuleihan, Gregory A Clines, Mimi I Hu, Claudio Marcocci, M Hassan Murad, Thomas Piggott, Catherine Van Poznak, Joy Y Wu, Matthew T Drake> ;The Journal of Clinical Endocrinology and Metabolism. 2023 Feb 15
- 27 citationsUse of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update.Andrea Eisen, Mark R Somerfield, Melissa K Accordino, Phillip S Blanchette, Mark J Clemons, Sukhbinder Dhesy-Thind, Melissa S Dillmon, Stella D'Oronzo, Glenn G Fletche...> ;Journal of Clinical Oncology. 2022 Mar 1
- 3 citationsEffect of antiresorptive therapy on aromatase inhibitor induced bone loss in postmenopausal women with early-stage breast cancer: A systematic review and meta-analysis...Aya Bassatne, Abir Bou Khalil, Marlene Chakhtoura, Asma Arabi, Catherine Van Poznak, Ghada El-Hajj Fuleihan> ;Metabolism. 2022 Mar 1
- Join now to see all
Committees
- Co-chair, Expert Panel, American Society of Clinical Oncology (ASCO) 2015 - Present
Hospital Affiliations
- University of Michigan Medical CenterAnn Arbor, Michigan
- Veterans Affairs Ann Arbor Healthcare SystemAnn Arbor, Michigan
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: